As of 2026-03-26, the Relative Valuation of Akero Therapeutics Inc (AKRO) is (77.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.65 USD, the upside of Akero Therapeutics Inc based on Relative Valuation is -242.7%.
The range of the Relative Valuation is (70.00) - (83.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 25.6x | 22.4x |
| Forward P/E multiples | 19.7x - 23.4x | 21.4x |
| Fair Price | (70.00) - (83.24) | (77.99) |
| Upside | -228.1% - -252.3% | -242.7% |
| Date | P/E |